Overview


According to FutureWise analysis the market for Collagen and Gelatin in 2023 is US$ 1.2 billion, and is expected to reach US$ 1.96 billion by 2031 at a CAGR of 6.30%.

The rising incidences of appalling diseases, rapidly increasing geriatric population, increased private and public financial assistance for developing regenerative medicines are some of the key driving factors of the market. Regenerative medicine promotes the potential restoration of injured tissues and organs. Multiple regenerative therapies for cardiovascular diseases, orthopaedic disorders and wound healing have been introduced over the years and have ben approved by the FDA. The usage of gelatin and collagen-based biomaterials in application related to regenerative medicine have been promoted intensely over the past few years. This method is currently being used on a broader scale for medical and environmental applications, thereby propelling the collagen and gelatin market for regenerative medicine growth.

  • GELITA AG,
  • Nitta Gelatin Inc.,
  • PB Gelatin,
  • Royal DSM,
  • Integra LifeSciences Holding Corporation,
  • Collagen Solutions plc,
  • Vornia Biomaterials Ltd.,
  • Collagen Matrix Inc.,
  • SYMATESE, NuCollagen LLC.

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Type

  • Collagen
  • Gelatin

By Source

  • Bovine
  • Porcine
  • Marine
  • Others

By Application

  • Wound Care
  • Orthopaedic
  • Cardiovascular
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

The market is categorised into type, source, application and region. The type segment is fragmented into collagen and gelatin. The source segment is bifurcated into bovine, porcine ad marine. The bovine source is predicted to account the largest collagen and gelatin market for regenerative medicine share and this is mainly due to the extensive availability and lower cost of bovine products. The application segment is classified into wound care, orthopaedic, cardiovascular and other applications. The orthopaedic segment is anticipated to lead the market, and this can be credited to the increased occurrence of osteoporosis, especially among the ageing population. The rising number of chronic wound cases shall people the growth of the wound care segment during the forecasted timeframe. Furthermore, the gelatin used for caring wounds gives a cooling effect and is also non-adhesive to wound tissues which helps in healing the wound in a shorter time and this shall help in the proliferation of the segment.

The North America region is expected to dominate the market and tis is due to the rising prevalence of periodontitis, growing incidences of cardiovascular diseases and diabetes owing to lifestyle changes like eating oily and fast foods. However, the Asia Pacific region is predicted to showcase substantial growth during the forecasted timeframe and this is mainly due to the rising diabetic and heart disorder patients in the region, increased research and development activities and key players expanding their businesses in the region.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key market trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the global collagen and gelatin market for regenerative medicine market e By Type, By Source, By Application and By Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
  • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Collagen and Gelatin Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Collagen and Gelatin Market for Regenerative Medicine Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Collagen and Gelatin Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Collagen and Gelatin Market for Regenerative Medicine, By Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Collagen
        2. Gelatin

  • 8.   Collagen and Gelatin Market for Regenerative Medicine, By Source Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Bovine
        2. Porcine
        3. Marine
        4. Others

  • 9.   Collagen and Gelatin Market for Regenerative Medicine, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Wound Care
        2. Orthopaedic
        3. Cardiovascular
        4. Others

  • 10.   North America Collagen and Gelatin Market for Regenerative Medicine Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Collagen and Gelatin Market for Regenerative Medicine Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Collagen and Gelatin Market for Regenerative Medicine Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Collagen and Gelatin Market for Regenerative Medicine Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. GELITA AG
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Nitta Gelatin Inc.
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. PB Gelatin
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Royal DSM
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Integra LifeSciences Holding Corporation
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Collagen Solutions plc
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Vornia Biomaterials Ltd.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Collagen Matrix Inc.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Symatese
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. NuCollagen LLC.
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients